4//SEC Filing
Hill Stephen J. 4
Accession 0001866154-25-000006
CIK 0001806952other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 8:31 PM ET
Size
4.8 KB
Accession
0001866154-25-000006
Insider Transaction Report
Form 4
Hill Stephen J.
Chief Operating Officer
Transactions
- Sale
Common Stock
2025-11-10$16.12/sh−95$1,531→ 15,750 total
Footnotes (1)
- [F1]Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.
Documents
Issuer
Lyell Immunopharma, Inc.
CIK 0001806952
Entity typeother
Related Parties
1- filerCIK 0001866154
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 8:31 PM ET
- Size
- 4.8 KB